# US 2025/0149170 A1 · Diffractometer-based global diagnostic systems and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0149170 A1
- Document ID: US20250149170A1
- Status: Published application
- Kind: A1
- Application number: 18/827,350
- Filed: 2024-09-06
- Published: 2025-05-08
- Earliest claimed: 2023-11-02
- Assignees: EosDx Inc.
- Applicants: EosDx Inc.
- Inventors: Alexander P. LAZAREV; Pavel LAZAREV
- Web page: https://patentgrep.com/patent/US20250149170A1

## CPC

- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 30/40: for processing medical images, e.g. editing
- G16H 40/67: for remote operation
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A method for diagnosing diseases in human patients can include providing a set of global X-ray diffraction (XRD) data to a global data center (GDC) and processing the set of global XRD data and categorizing it into data clusters, where each data cluster corresponds to a diagnostic indicator for assessment of a physiological or pathological condition. The method can further include communicating local XRD data and local patient data from a local autonomous cell (LAC) to the GDC, where the local XRD data includes information about a tissue sample measured using a tissue diffractometer of the LAC, and wherein the tissue sample includes skin. The method can further include processing the local XRD data, comparing it with the data clusters to determine a local diagnostic indicator for the local patient, and communicating the local diagnostic indicator to the LAC.

## Claims

### Claim 1

A method for diagnosing diseases in human patients comprising:
providing a set of global X-ray diffraction data to a global data center;
processing the set of global X-ray diffraction data and categorizing the processed set of global X-ray diffraction data into data clusters using a processor coupled to the global data center, wherein each data cluster corresponds to a diagnostic indicator for assessment of a physiological or pathological condition;
communicating local X-ray diffraction data and local patient data of a local patient from a local autonomous cell to the global data center, wherein the local X-ray diffraction data comprises information about a tissue sample measured using a tissue diffractometer of the local autonomous cell, and wherein the tissue sample comprises skin;
processing the local X-ray diffraction data and comparing the processed local X-ray diffraction data with the data clusters to determine a local diagnostic indicator for the local patient using the processor; and
communicating the local diagnostic indicator from the global data center to the local autonomous cell.

### Claim 2 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the diagnostic indicator comprises a probability score for a likelihood of one or more physiological or pathological conditions.

### Claim 3 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the tissue diffractometer is configured to perform small angle X-ray scattering measurements or is configured to perform wide angle X-ray scattering measurements.

### Claim 4 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the tissue sample further comprises a lipid, α-keratin, or collagen.

### Claim 5 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the local X-ray diffraction data comprises X-ray diffraction data from an in vivo measurement or an in vitro measurement of the tissue sample.

### Claim 6 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the set of global X-ray diffraction data is provided from a certain geographical region or nation.

### Claim 7 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the processor is in the cloud, and uses cloud computing to process data using a distributed network of computers.

### Claim 8 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the global data center further comprises the processor.

### Claim 9 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, further comprising an analytical center in communication with the global data center, wherein the analytical center comprises the processor.

### Claim 10 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, further comprising:
measuring a plurality of tissue samples to produce a plurality of local X-ray diffraction data of a plurality of local patients using a plurality of tissue diffractometers of a plurality of local autonomous cells, wherein:
the local patient is one of the plurality of local patients;
the local X-ray diffraction data of the local patient is one of the plurality of local X-ray diffraction data from the plurality of local patients;
the tissue diffractometer is one of the plurality of tissue diffractometers;
the local autonomous cell is one of the plurality of local autonomous cells; and
a plurality of local patient data is associated with the plurality of local patients;
communicating the plurality of local X-ray diffraction data and the plurality of local patient data from the plurality of local autonomous cells to the global data center;
processing the plurality of local X-ray diffraction data using the processor;
comparing the plurality of processed local X-ray diffraction data with the data clusters to determine a plurality of local diagnostic indicators for the plurality of local patients;
communicating each of the plurality of local diagnostic indicators from the global data center to each of the plurality of local autonomous cells.

### Claim 11 (depends on 10)

The method for diagnosing diseases in human patients of claim 10, wherein local autonomous cells of the plurality of local autonomous cells are in different geographic locations.

### Claim 12 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the tissue sample comprises one or more of a surgical sample, a resection sample, a pathology sample, or a biopsy sample.

### Claim 13 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the communicating the local X-ray diffraction data and the local patient data from the local autonomous cell to the global data center is done by the local patient or a medical services provider of the local patient using a user interface.

### Claim 14 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, further comprising communicating the local diagnostic indicator from the local autonomous cell to the local patient or a medical services provider of the local patient using a user interface.

### Claim 15 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, further comprising encrypting the local X-ray diffraction data and the local patient data using a data encryption device coupled to the tissue diffractometer, wherein the communicating the local measurement data and the local patient data from the local autonomous cell to the global data center comprises communicating the encrypted local X-ray diffraction data and encrypted the local patient data from the local autonomous cell to the global data center.

### Claim 16 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the global data center further comprises a global database stored on a central server or in the cloud, wherein the global database comprises the set of global X-ray diffraction data.

### Claim 17 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, further comprising depersonalizing the local X-ray diffraction data, the local patient data, or any combination thereof before communicating the local X-ray diffraction data and the local patient data from the local autonomous cell to the global data center, wherein the communicating the local X-ray diffraction data and the local patient data from the local autonomous cell to the global data center comprises communicating the depersonalized local X-ray diffraction data and the depersonalized local patient data from the local autonomous cell to the global data center.

### Claim 18 (depends on 17)

The method for diagnosing diseases in human patients of claim 17, wherein a key for mapping the depersonalized local X-ray diffraction data, the local patient data, or any combination thereof is stored in a local institutional database or in an individual personal file of the local patient.

### Claim 19 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the processing the set of global X-ray diffraction data and categorizing the processed set of global X-ray diffraction data into the data clusters comprises performing a statistical analysis on the processed set of global X-ray diffraction data.

### Claim 20 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the processing the set of global X-ray diffraction data and categorizing the processed set of global X-ray diffraction data into the data clusters comprises using a machine learning algorithm.

### Claim 21 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the local patient data comprises descriptions or data related to symptoms of the local patient comprising one or more of sleep disorders, insomnia, sudden awakenings, somnambulism, apnea, disorders of cerebral circulation, electroencephalogram data, sudden convulsions and fainting, headaches and dizziness, and traumatic brain injuries and symptoms thereof.

### Claim 22 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the physiological or pathological condition comprises prostate cancer.

### Claim 23 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the physiological or pathological condition comprises one of more of breast cancer, brain cancer, bone cancer, lung cancer, cervical cancer, bladder cancer, head cancer, neck cancer, kidney cancer, intestinal cancer, liver cancer, ovarian cancer, pancreatic cancer, prostate cancer, skin cancer, throat cancer, oral cancer, vaginal cancer, sinus tachycardia of the heart, atrial extra-systoles, ventricular extra-systoles, acute myocardial infarction, heart valve defect, cardiomyopathy, ventricular hypertrophy, heart failure, arrhythmia, atrial fibrillation of the heart, pericarditis, bradycardia of the heart, myocarditis, ischemic stroke, neurological stroke, Alzheimer's disease, glioblastoma, extra-cerebral tumors, bacterial endocarditis (inflammation of inner lining of the heart), and meningococcal meningitis (inflammation of membranes of the brain and spinal cord).

### Claim 24 (depends on 1)

The method for diagnosing diseases in human patients of claim 1, wherein the communicating the local X-ray diffraction data and the local patient data from the local autonomous cell to the global data center is done by mail, airmail, courier mail or e-mail.

### Claim 25

A system comprising:
a local autonomous cell comprising a tissue diffractometer configured to measure local X-ray diffraction data of a local tissue sample of a local patient, wherein the local tissue sample comprises skin;
a global data center in communication with the local autonomous cell, wherein the global data center comprises a set of global X-ray diffraction data stored in a global database; and
a processor coupled to the global data center, the processor configured to:
process the set of global X-ray diffraction data and categorize the processed set of global X-ray diffraction data into data clusters, wherein each data cluster corresponds to a diagnostic indicator for assessment of a physiological or pathological condition; and
process the local X-ray diffraction data and compare the processed local X-ray diffraction data with the data clusters to determine a local diagnostic indicator for the local patient.
